Elekta and Royal Phillips Electronics Establish Research Consortium to Leverage a Breakthrough in Cancer Care With Integration of a Linear Accelerator and MR Imaging

Published: Oct 25, 2012

Stockholm, SWEDEN and Amsterdam, THE NETHERLANDS October 25, 2012 – Elekta AB (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announced that they will expand a joint program to develop a breakthrough in cancer care with an imaging-treatment platform that merges radiation therapy and magnetic resonance imaging (MRI) technology in a single treatment system. The program for development will include a research consortium of leading radiation oncology centers and clinicians, which today includes the University Medical Center Utrecht (the Netherlands).

Back to news